These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33680093)

  • 21. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
    Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
    Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The JFK BIG study: the impact of LSVT BIG
    Isaacson S; O'Brien A; Lazaro JD; Ray A; Fluet G
    J Phys Ther Sci; 2018 Apr; 30(4):636-641. PubMed ID: 29706722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.
    Miles A; Jardine M; Johnston F; de Lisle M; Friary P; Allen J
    J Neurol Sci; 2017 Dec; 383():180-187. PubMed ID: 29246611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplitude-oriented exercise in Parkinson's disease: a randomized study comparing LSVT-BIG and a short training protocol.
    Ebersbach G; Grust U; Ebersbach A; Wegner B; Gandor F; Kühn AA
    J Neural Transm (Vienna); 2015 Feb; 122(2):253-6. PubMed ID: 24872078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.
    Bryans LA; Palmer AD; Anderson S; Schindler J; Graville DJ
    J Commun Disord; 2021; 89():106031. PubMed ID: 33259945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of LSVT® BIG on standing balance in a Parkinson's patient: A case report.
    Iwai M; Koyama S; Takeda K; Hirakawa Y; Motoya I; Kumazawa N; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Tanabe S
    Physiother Res Int; 2021 Oct; 26(4):e1921. PubMed ID: 34482577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).
    Sackley CM; Smith CH; Rick CE; Brady MC; Ives N; Patel S; Woolley R; Dowling F; Patel R; Roberts H; Jowett S; Wheatley K; Kelly D; Sands G; Clarke CE;
    Pilot Feasibility Stud; 2018; 4():30. PubMed ID: 29344405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
    Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
    Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lee Silverman Voice Treatment BIG
    Proffitt RM; Henderson W; Scholl S; Nettleton M
    Am J Occup Ther; 2018; 72(5):7205210010p1-7205210010p6. PubMed ID: 30157019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease.
    Fox C; Ebersbach G; Ramig L; Sapir S
    Parkinsons Dis; 2012; 2012():391946. PubMed ID: 22530161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial.
    Sackley CM; Smith CH; Rick C; Brady MC; Ives N; Patel R; Roberts H; Dowling F; Jowett S; Wheatley K; Patel S; Kelly D; Sands G; Clarke C
    Trials; 2014 Jun; 15():213. PubMed ID: 24908096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial.
    Scobie S; Jowett S; Lambe T; Patel S; Woolley R; Ives N; Rick C; Smith C; Brady MC; Clarke C; Sackley C
    Pilot Feasibility Stud; 2021 Aug; 7(1):154. PubMed ID: 34372913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
    Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
    Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of the Lee Silverman Voice Treatment-BIG Intervention in Stroke.
    Proffitt R; Henderson W; Stupps M; Binder L; Irlmeier B; Knapp E
    OTJR (Thorofare N J); 2021 Jan; 41(1):40-46. PubMed ID: 32578496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes Following LSVT BIG in a Person With Idiopathic Normal Pressure Hydrocephalus: A Case Report.
    Fillmore S; Cavalier G; Franke H; Hajec M; Thomas A; Moriello G
    J Neurol Phys Ther; 2020 Jul; 44(3):220-227. PubMed ID: 32516302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.